Jeżeli nie znalazłeś poszukiwanej książki, skontaktuj się z nami wypełniając formularz kontaktowy.

Ta strona używa plików cookies, by ułatwić korzystanie z serwisu. Mogą Państwo określić warunki przechowywania lub dostępu do plików cookies w swojej przeglądarce zgodnie z polityką prywatności.

Wydawcy

Literatura do programów

Informacje szczegółowe o książce

Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment - ISBN 9780124080782

Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment

ISBN 9780124080782

Autor: Schaefer, ChristofPeters, Paul W.J.Miller, Richard K

Wydawca: Elsevier

Dostępność: 3-6 tygodni

Cena: 400,05 zł

Przed złożeniem zamówienia prosimy o kontakt mailowy celem potwierdzenia ceny.


ISBN13:      

9780124080782

ISBN10:      

0124080782

Autor:      

Schaefer, ChristofPeters, Paul W.J.Miller, Richard K

Oprawa:      

Hardback

Rok Wydania:      

2014-10-09

Tematy:      

MMGT

Drugs During Pregnancy and Lactation, 3rd Edition is a quick and reliable reference for all those working in disciplines related to fertility, pregnancy, lactation, child health and human genetics who prescribe or deliver medicinal products, and to those who evaluate health and safety risks. Each chapter contains twofold information regarding drugs that are appropriate for prescription during pregnancy and an assessment of the risk of a drug when exposure during pregnancy has already occurred. Thoroughly updated with current regulations, references to the latest pharmacological data, and new medicinal products, this edition is a comprehensive resource covering latest knowledge and findings related to drugs during lactation and pregnancy.



Provides evidence-based recommendations to help clinicians make appropriate recommendationsUniquely organized and structured according to drug class and treatment indications to offer authoritative clinical content on potential adverse effects  Highlights new research developments from primary source about working mechanism of substances that cause developmental disorders

1. General Commentary on drug therapy and drug risks in pregnancy
2. Specific drug therapties during pregnancy
2.1 Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications
2.2 Allergy and hyosensitization therapy
2.3 Antiasthmatic and cough medication
2.4 Nausea and vomiting in pregnancy
2.5 Gastro-intestinal medications, hyoplipidemic agents and spasmolytics
2.6 Anti-infective Agents
2.7 Vaccines and immunoglobulins
2.8 Heart and blood medications
2.9 Anticoagulants, thrombocyte aggregation inhibitors, fibrinolyrics,and volume replacement agents
2.10 Epilepsy and antiepileptic medications
2.11 Psychotropic drugs
2.12 Immunosuppression, rheumatic diseases, multiple sclerosis, and Wilson's disease
2.13 Antineoplastic drugs
2.14 Uterine contraction agents, tocolytics, vaginal therapeutics and local contraceptives
2.15 Hormones
2.16 General and local anesthetics and muscle relaxants
2.17 Dermatological medications and local therapeutics
2.18 Vitamins, minerals and trace elements
2.19 Herbs during pregnancy
2.20 Diagnostic agents
2.21 Recreational drugs
2.22 Poisonings and toxins
2.23 Occupational, industrial and environmental agents
3. General commentary on drug therapy and drug risk during lactation
3.1 The advances of breastfeading versus the risks of maternal medication
3.2 The passage of medication into the mother's milk
3.3 Infant characteristics
3.4 Milk plasma ratio
3.5 Amount of medication in the milk and relative dose
3.6 Toxicity of medications in the mother's milk
3.7 Medications that affect lactation
3.8 Breastfeeding support
4. Specific drug therapies during lactation
4.1 Analgesics, antiphlogistics and anesthetics
4.2 Antiallergics, antiasthmatics and antitussives
4.3 Gastrointestinal drugs
4.4 Anti-infectives
4.5 Vaccines and immunoglobulins
4.6 Cardiovascular drugs and diuretics
4.7 Anticoagulants, thrombocyte aggregation inhibitors and fibrinolytics
4.8 Antiepileptics
4.9 Psychotropic drugs
4.10 Immunomodulating and antineoplastic agents
4.11 Hormones and hormone antagonists
4.12 Dermatological medication and local therapeutics
4.13 Alternative remedies, vitamins, and minerals
4.14 Contrast media, radionuclides and diagnostics
4.15 Infections during breastfeeding
4.16 Recreational drugs
4.17 Plant toxins
4.18 Industrial chemicals and environmental contaminants
4.18.1 Persistent organochlorine compounds (pesticides, polychlorinated biphenyls and dioxins)
4.18.2 Mercury
4.18.3 Lead
4.18.4 Cadmium
4.18.5 Other contaminants
4.18.6 Breasfeeding despite environmental contaminants?
4.18.7 Breastfeeding and the workplace

Koszyk

Książek w koszyku: 0 szt.

Wartość zakupów: 0,00 zł

ebooks
covid

Kontakt

Gambit
Centrum Oprogramowania
i Szkoleń Sp. z o.o.

Al. Pokoju 29b/22-24

31-564 Kraków


Siedziba Księgarni

ul. Kordylewskiego 1

31-542 Kraków

+48 12 410 5991

+48 12 410 5987

+48 12 410 5989

Zobacz na mapie google

Wyślij e-mail

Subskrypcje

Administratorem danych osobowych jest firma Gambit COiS Sp. z o.o. Na podany adres będzie wysyłany wyłącznie biuletyn informacyjny.

Autoryzacja płatności

PayU

Informacje na temat autoryzacji płatności poprzez PayU.

PayU banki

© Copyright 2012: GAMBIT COiS Sp. z o.o. Wszelkie prawa zastrzeżone.

Projekt i wykonanie: Alchemia Studio Reklamy